Overwhelming scientific evidence shows that excess sun exposure without sunscreen increases the risk of developing skin cancer. Banning key ingredients in effective sunscreens will unnecessarily reduce the selection of safe and effective sunscreen products available.
Today, the United States Senate Health, Education, Labor and Pensions (HELP) Committee approved S. 2315, the Over-the-Counter Drug Safety, Innovation, and Reform Act by a 22-1 vote.
CHPA thanks Governor Walker for signing this important bill into law as well as Senator Stroebel and Representative Kremer for their leadership and commitment to passing legislation aimed at addressing the issue of teen OTC cough medicine abuse
CHPA released the following statement today by President and CEO, Scott Melville, applauding the introduction of The Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
CHPA welcomes the opportunity to comment on Nicotine Replacement Therapies (NRT). A number of our member companies hold new drug applications or abbreviated new drug applications for NRT. As such, we have an interest in the subject matter of FDA’s notice.
The 2017 results from the National Institute on Drug Abuse and University of Michigan’s annual drug abuse survey were released today showing that the percentage of teens using OTC cough medicine containing DXM to get high remains at just three percent, the lowest level recorded since 2015.
CHPA appreciates that FDA has taken the time to review the data associated with certain isolated or synthetic carbohydrates not listed as a dietary fiber and looks forward to engaging with FDA in efforts to clarify and improve the regulation of all dietary supplements.
Today, CHPA announced a new initiative to support retailers in states that have adopted laws prohibiting the sale of OTC medicines containing the cough suppressant dextromethorphan to minors. The announcement comes on the heels of Nevada’s enactment of a DXM age-restriction law last week.
CHPA strongly supports the OTC Monograph system as a balanced framework for regulating OTC medicines containing ingredients with a proven history of safe use.
